Accumulation of Temozolomide-Induced Apoptosis, Senescence and DNA Damage by Metronomic Dose Schedule: A Proof-of-Principle Study with Glioblastoma Cells

SIMPLE SUMMARY: Severe toxic side effects do not allow unlimited dose escalation of anticancer drugs, and the doses used in cancer therapy are therefore often rather low regarding the required target concentration. For temozolomide (TMZ), which is used in glioblastoma therapy, single high dose proto...

Descripción completa

Detalles Bibliográficos
Autores principales: Beltzig, Lea, Stratenwerth, Björn, Kaina, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699541/
https://www.ncbi.nlm.nih.gov/pubmed/34944906
http://dx.doi.org/10.3390/cancers13246287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699541/
https://www.ncbi.nlm.nih.gov/pubmed/34944906
http://dx.doi.org/10.3390/cancers13246287

Ejemplares similares